AB 1881: Valley Fever testing.
- Session Year: 2017-2018
- House: Assembly
- Latest Version Date: 2018-03-14
Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law also supports research into the development of a vaccine to protect against coccidioidomycosis, also known as Valley Fever.
This bill would encourage a medical provider to order, or a city or county public health laboratory to use, 2 specified blood tests in suspected cases of coccidioidomycosis, but would allow the ordering or use of other types of tests. The bill would require the department to develop standardized methodology for specified coccidioidomycosis tests to ensure comparable sensitivity and specificity among laboratories, among other things.
Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law also supports research into the development of a vaccine to protect against coccidioidomycosis, also known as Valley Fever.
This bill would standardize testing for coccidioidomycosis by requiring encourage a medical provider to order, or a city or county public health laboratory to use, 2 specified blood tests in suspected cases of coccidioidomycosis. By imposing specific coccidioidomycosis testing requirements on local health departments, the bill would create a state-mandated local program. coccidioidomycosis, but would allow the ordering or use of other types of tests. The bill would require the department to develop standardized methodology for specified coccidioidomycosis tests to ensure comparable sensitivity and specificity among laboratories, among other things.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.Existing law requires the State Department of Public Health to establish a list of reportable communicable and noncommunicable diseases and conditions and specify the timeliness requirements related to the reporting of each disease and condition. Existing law also supports research into the development of a vaccine to protect against coccidioidomycosis, also known as Valley Fever.
This bill would standardize testing for coccidioidomycosis by requiring a medical provider to order, or a city or county public health laboratory to use, 2 specified blood tests in suspected cases of coccidioidomycosis. By imposing specific coccidioidomycosis testing requirements on local health departments, the bill would create a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that, if the Commission on State Mandates determines that the bill contains costs mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
(c)The department shall develop standardized methodology for tests ordered or used pursuant to subdivision (a), in a suspected case of coccidioidomycosis, also known as Valley Fever, including, but not limited to, methodology to ensure comparable sensitivity and specificity among laboratories.
(a)A medical provider shall is encouraged to order, or a city or county public health laboratory shall is encouraged to use, both of the following serologic tests in a suspected case of coccidioidomycosis, also known as Valley Fever:
(a)(1)An immunodiffusion test to determine the presence of coccidioides precipitin immunoglobulin M antibody or immunoglobulin G antibody.
(b)(2)A complement fixation test to determine the immunoglobulin G titer.
(b)A medical provider may order, or a city or county public health laboratory may use, a coccidioides antigen enzyme immunoassay or other test in a suspected case of coccidioidomycosis.
(c)The department shall develop standardized methodology for tests ordered or used pursuant to subdivision (a), including, but not limited to, methodology to ensure comparable sensitivity and specificity among laboratories.
SEC. 2.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.A medical provider shall order, or a city or county public health laboratory shall use, both of the following serologic tests in a suspected case of coccidioidomycosis, also known as Valley Fever:
(a)An immunodiffusion test to determine the presence of coccidioides precipitin or immunoglobulin G antibody.
(b)A complement fixation test to determine the immunoglobulin G titer.
SEC. 2.If the Commission on State Mandates determines that this act contains costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
|
Date
|
Status
|
|---|---|
| Mar 20, 2018 | In committee: Set, first hearing. Hearing canceled at the request of author. |
| Mar 15, 2018 | Re-referred to Com. on HEALTH. |
| Mar 14, 2018 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Mar 5, 2018 | Re-referred to Com. on HEALTH. |
| Mar 1, 2018 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Jan 29, 2018 | Referred to Com. on HEALTH. |
| Jan 18, 2018 | From printer. May be heard in committee February 17. |
| Jan 17, 2018 | Read first time. To print. |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Date of Hearing: March 20, 2018
ASSEMBLY COMMITTEE ON HEALTH
Jim Wood, Chair
ABPCA Bill Id:AB 1881
Author:Fong – As Amended Ver:March 14, 2018
SUBJECT: Valley Fever testing.
SUMMARY: Requires the Department of Public Health (DPH) to develop standardized methodology for tests ordered or used in a suspected case of coccidioidomycosis, also known as Valley Fever, including but not limited to, methodology to ensure comparable sensitivity and specificity among laboratories.
EXISTING LAW:
- Requires, through federal regulation, any laboratory testing human specimens for diseases comply with federal laboratory practices and standards put forth by Clinical Laboratory Improvement Amendments (CLIA) of 1988.
- Requires an approved clinical public health laboratory to report findings of reportable diseases including Valley Fever, to the local health officer for the local health jurisdiction where the patient resides.
FISCAL EFFECT: This bill has not yet been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the authors, Valley Fever has affected every region in California, but has been particularly endemic to the Central Valley. Statewide there were over 5,300 cases reported in 2016— a jump of 71% over 2015. Over 40% of these cases were from Kern County alone. The authors state that Valley Fever is known as the “silent epidemic” and the number of cases continues to increase. The authors conclude that due to the alarming increase in cases, we need to ensure testing consistency across medical labs in order for Valley Fever patients to receive the quality care they need and enable them to make a swift recovery.
- BACKGROUND.
- Valley Fever. Valley Fever is an infectious disease caused by a fungus, Coccidioides, which is found in arid soil and desert-like regions of California, the southwestern region of the U.S., parts of Mexico, Central America, and South America. Individuals and domestic animals can become infected with Valley Fever through breathing in the microscopic Coccidioides fungus spores. Anyone who lives, works, or visits areas with the contaminated soil is at risk for Valley Fever. It is important to note that individuals and/or animals infected with Valley Fever are not contagious. The majority of counties in California have reported cases of Valley Fever, but a large portion of Valley Fever cases are found in the California Central Valley. According to DPH, approximately 60% of infected individuals will not present any symptoms. However, for many individuals infected with Valley Fever they will present with flu-like symptoms which last from a few weeks to a few months. Approximately 5-10% of individuals infected will develop severe Valley Fever and may suffer life-long complications. In very rare cases Valley Fever can be fatal.
There is no vaccine to prevent infection or cure for those who have been infected, but current research is working towards this goal. State funding for the Valley Fever Vaccine Project began with a budget augmentation request by then-Assemblymember Ashburn for $700,000 in 1997-98. In 2009, the Budget Act included an ongoing appropriation of $1 million to continue research activities earmarked toward the development of a vaccine. Funding was subsequently discontinued in 2010. In 2015, SB 115 (Fuller) was introduced which would have appropriated $1 million from the General Fund to DPH for Valley Fever vaccine research. SB 115 was held in the Assembly Appropriations Committee. Numerous similar allocation requests between 2002 and 2014 were held in the Assembly Appropriations Committee. Currently, Assemblymembers Salas and Fong have budget proposals regarding appropriations for Valley Fever vaccine research and a Valley Fever public awareness campaign.
- Laboratory Standards. Public health laboratories adhere to CLIA which was enacted to ensure the accuracy and reliability of laboratory testing. According to DPH, setting standardized laboratory methodology falls within the jurisdiction of the federal government. DPH also notes, because test methods evolve and new test systems can be introduced, DPH would be continually evaluating methods with little, if any impact on laboratory practices.
- RELATED LEGISLATION.
- AB 1787 (Salas and Fong) requires DPH to establish an annual deadline beginning on March 1, 2019, for local health officers (LHOs) to report all cases of Valley Fever to DPH. AB 1787 is pending in the Assembly Health Committee.
- AB 1788 (Salas and Fong) requires DPH, for the purpose of reporting confirmed cases of Valley Fever, to use laboratory criteria with or without clinical criteria. AB 1788 is pending in the Assembly Health Committee.
- AB 1789 (Salas and Fong) requires the Occupational Safety and Health Standards Board to adopt occupational safety and health standard for state public work projects to prevent Valley Fever. AB 1789 passed 6-0 in the Assembly Labor and Employment Committee and is pending in the Assembly Appropriations Committee.
- AB 1790 (Salas and Fong) requires mandatory training for physicians and surgeons on preventing, diagnosing, and treating Valley Fever. AB 1790 is pending in the Assembly Business and Professions Committee.
- AB 1880 (Fong and Salas) requires DPH to collect data on Valley Fever cases on or before April 1st of each year and would require DPH to report to LHOs regarding changes in Valley Fever cases. AB 1880 is pending in the Assembly Health Committee.
- PREVIOUS LEGISLATION. AB 1279 (Salas) of 2017 would have required DPH to develop and implement a public outreach program to educate individuals about Valley Fever. AB 1279 was vetoed by the Governor, who stated:
“I am returning Assembly Bill 1279 without my signature.
This bill requires the Department of Public Health to develop outreach programs to educate the public about Valley Fever.
The department already provides fact sheets, brochures, posters, and other educational materials to raise awareness of this disease. Expanding this program would necessitate additional resources which should be considered along with other funding requests as part of the budget process.”
- POLICY COMMENT. Currently, public health laboratories follow federal standards regarding testing for various diseases. As noted by DPH, setting standardized laboratory methodology falls within the jurisdiction of the federal government. As such, it is unclear if DPH has the capacity to develop the testing methodology called for in this bill.
REGISTERED SUPPORT / OPPOSITION:
Support
Acton Town Council (prior version)
Bakersfield City Council (prior version)
Valley Fever Americas Foundation (prior version)
Wonderful Company LLC (prior version)
Opposition
None on file.
Analysis Prepared by: Monica Montano / HEALTH / (916) 319-2097
Bill Author
Bill Co-Author(s):